What BOTALYS does

BOTALYS is a Belgian biotech company founded in 2011 that develops and supplies premium botanical ingredients to the nutraceutical and cosmeceutical industries. Its core technology is Biomimetic Indoor Farming — a proprietary controlled-environment agriculture system that replicates the environmental conditions of wild botanical habitats (light, atmosphere, thermal, hygroscopic, substrate, and ecosystem variables) inside a 2,000 sqm vertical farm in Ghislenghien, Belgium, with a current production capacity of 50–60 tonnes per year. This enables consistent, standardized bioactive profiles equivalent to wild-harvested specimens while eliminating contamination, adulteration, and sustainability issues associated with wild sourcing.

The company's commercial portfolio spans core ingredients (Korean Red Ginseng with 10% rare ginsenosides, Fjord Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen), processed variants (Red and Black Ginseng), and emerging cosmetic actives (Sichuan Red Sage and others). BOTALYS generates revenue through B2B ingredient sales on a quote-based, multi-year contract model to nutraceutical manufacturers (Throne, Terry Naturally, Ora, Therascience, Nutri-Logics, Laboratoire Optim) and cosmeceutical brands (L'Oréal, Seppic), with strategic co-development partnerships creating exclusive ingredient IP for major customers including Haleon (consumer healthcare) and L'Oréal/Brightseed (cosmetics with AI-powered discovery).

BOTALYS operates with 11–50 employees across its Belgian HQ and US subsidiary (Austin, TX, opened 2023), supported by ~$20M+ in cumulative funding from investors including ALIAD (Air Liquide's VC arm), S.R.I.W., Vives Louvain Technology Fund, WapInvest, Teseo Capital, and Horizon 2020. The company has built a vertically integrated seed-to-ingredient pipeline with EU-quality certifications (ISO 9001, EFfCI GMP, FSSC 22000, GLOBALG.A.P., Halal, Kosher) and clinically validated efficacy claims across its lead ingredients.

Name

BOTALYS

Legal name

BOTALYS S.A.

Website

https://botalys.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

BOTALYS is a Belgian biotech that develops premium, standardized botanical ingredients for nutraceutical and cosmeceutical manufacturers using proprietary Biomimetic Indoor Farming technology, replicating wild-growing conditions in vertical farms.

Ownership category

akta.pro rank

Product category

Nutraceutical & Cosmeceutical Botanical Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)

akta.pro secondary industries

Greenhouse Herb & Microgreens Production (Culinary Herbs, Microgreens) (AFAGAHAC), Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

Keywords

• Botanical ingredients
• Nutraceutical ingredients
• Cosmeceutical actives
• Biomimetic indoor farming
• Medicinal plant extracts

Headquarters

HQ city

Ghislenghien

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Premium Botanical Ingredients — B2B Ingredient Sales: BOTALYS develops and sells ultra-pure, standardized botanical ingredient powders and extracts (Korean Red Ginseng, Fjord Rhodiola, Red Sage, and others in development) to nutraceutical and cosmeceutical manufacturers. Ingredients are supplied with certifications including DNA identification, vegan, halal, and kosher, along with comprehensive quality analyses. The company operates a co-development model where it partners with clients to develop exclusive botanical ingredients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

BOTALYS develops, cultivates, and supplies ultra-pure, standardized premium botanical ingredient powders and extracts — including Korean Ginseng (Panax ginseng), Fjord Rhodiola (Rhodiola rosea), Red & Black Ginseng variants, and an emerging cosmetic active ingredients portfolio — for nutraceutical and cosmeceutical manufacturers. Production relies on its proprietary Biomimetic Indoor Farming vertical-farm technology, which replicates wild botanical habitats to deliver batch-to-batch standardized bioactive profiles equivalent to wild-harvested specimens, with full traceability from seed to ingredient and certifications covering DNA identification, vegan, halal, and kosher compliance. The company also operates a co-development platform enabling the development of exclusive, proprietary botanical ingredients with industry partners from feasibility through industrial scale-up.

Product overview

BOTALYS is a Belgian supplier and developer of premium botanical ingredients for the nutraceutical and cosmeceutical industries. The company operates a proprietary Biomimetic Indoor Farming platform that enables the precise control of plant growth conditions to produce consistent, high-quality botanicals equivalent to wild-harvested plants. Core products include Korean Ginseng (Panax ginseng) for mental stamina and Fjord Rhodiola (Rhodiola rosea) for adaptogenic benefits, alongside processed variants (Red & Black Ginseng). The company also offers a New Plant Development Platform for co-development partnerships to create exclusive botanical ingredients, with emerging cosmetic active ingredients in development. All ingredients are produced in Belgium using vertically integrated seed-to-ingredient processes.

Differentiator

Problem solved

Functional benefit

Products and services

• Korean Ginseng (Panax ginseng) Premium botanical ingredient developed using BOTALYS' Biomimetic Indoor Farming technology, specifically formulated to promote mental stamina with clinically demonstrated efficacy against factors of mental load including focus, stress, and memory. Contains 10% rare ginsenosides (Rg3, Rg5, Rk1). For nutraceutical manufacturers.
• Fjord Rhodiola (Rhodiola rosea) Unique Nordic Rhodiola rosea cultivar developed over 4 years of R&D, producing a potent European Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen. Known for boosting physical and mental stamina. For nutraceutical and adaptogenic supplement manufacturers.
• Red & Black Ginseng Processed ginseng products derived from BOTALYS' Korean Ginseng, including steam-cooked red ginseng and multi-cycle black ginseng, with enhanced bioactive ginsenoside profiles for various health applications. For nutraceutical manufacturers.
• Cosmetic Active Ingredients Dedicated portfolio of botanical ingredients being developed for cosmetic applications, targeting the cosmeceutical market. Includes Sichuan Red Sage (Salvia miltiorrhiza) and other actives in development for skincare and personal care formulations. For cosmetic and personal care manufacturers.
• New Plant Development Platform Co-development platform enabling the development of rare, high-performance botanical ingredients from feasibility to industrial scale through exclusive partnerships with industry leaders. Covers technical specifications, non-technical validation, rare plant sourcing, vitroplant production, cultivar selection, process optimization, and industrial scale-up. For enterprise partners in nutraceuticals, cosmeceuticals, and consumer health.

Quantifiable outcome

• 74% memory capacity recovery in aged mice supplemented with BOTALYS Red Ginseng vs. young mice in Y-maze test (50 mg/kg/day, 8 days)
• +6 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• HaleoncoreStrategic or Co-development Partner · 16 October 2025Strategic collaboration announced October 16, 2025 to develop innovative botanical ingredients using BOTALYS' indoor cultivation platform and Haleon's consumer healthcare portfolio. Partnership focuses on scientific and regulatory standards, sustainability, and advancing plant-based health solutions through multiple research and development phases.
• L'Oréal & BrightseedcoreStrategic or Co-development Partner · 1 January 2024Partnership launched in 2024 with L'Oréal and Brightseed (AI-powered plant compound exploration company) as part of L'Oréal's Green Sciences incubator and R&I Exploration Trailblazer program. The collaboration leverages AI to explore plant compounds for cosmetic applications using BOTALYS' botanical platform.
• SeppiccoreStrategic or Co-development Partner · 1 January 2023Co-development and distribution partnership launched in 2023. Seppic and BOTALYS signed a partnership for co-development and distribution of botanical ingredients, combining Seppic's formulation expertise and distribution network with BOTALYS' cultivation technology.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Indena: Italian-headquartered developer and manufacturer of standardized botanical extracts for the pharmaceutical, nutraceutical, and cosmeceutical industries. Directly comparable to BOTALYS in target customers (premium B2B ingredient buyers), botanical standardization expertise, and clinical efficacy focus.
• Sabinsa: US-based manufacturer of standardized botanical extracts and nutraceutical ingredients with a broad branded SKU portfolio. Highly comparable to BOTALYS as a science-driven, vertically integrated botanical ingredient supplier serving nutraceutical and personal care brands globally.
• Euromed: Spanish producer of standardized botanical and fruit extracts for nutraceutical and pharmaceutical applications. Comparable to BOTALYS in standardized extract positioning, B2B sales to health brands, and emphasis on clinical-grade quality documentation.
• OmniActive Health Technologies: Supplier of scientifically validated, naturally sourced ingredients for dietary supplements and functional foods. Comparable to BOTALYS in premium, evidence-led botanical ingredient positioning for global nutraceutical brands.
• Linnea: Swiss-based manufacturer of high-purity botanical extracts and active pharmaceutical ingredients from medicinal plants. Comparable to BOTALYS in vertically integrated, GMP-grade botanical manufacturing for pharma-adjacent and nutraceutical buyers.

Broad incumbents

• Naturex (Givaudan): Naturex, now part of Givaudan, is one of the largest global suppliers of plant-based extracts for food, nutraceutical, and cosmetic applications. A broad incumbent offering overlapping standardized botanical capabilities at much greater scale than BOTALYS, including conventional and some cultivated sourcing.
• Kemin Industries: Global ingredient manufacturer serving human/animal nutrition, food, and personal care with botanical extracts and specialty ingredients. Broader portfolio than BOTALYS but overlaps in standardized plant-based actives for nutraceutical and cosmetic applications.
• Kerry Group: Global taste and nutrition company supplying functional ingredients, botanical extracts, and nutraceutical solutions to food, beverage, and supplement manufacturers. Broader incumbent with significant overlap in botanical ingredient supply to large CPG customers.

Emerging players

• Pharmactive Biotech Products: Spanish specialist in premium, sustainably sourced botanical extracts for nutraceutical and functional food markets. Comparable to BOTALYS in B2B premium botanical positioning, clinical substantiation, and focus on unique, differentiated plant actives.
• ActivInside: French developer of clinically supported, plant-based active ingredients for the nutraceutical and dermo-cosmetic markets. Closely comparable to BOTALYS in premium B2B botanical actives, clinical efficacy positioning, and focus on cosmeceutical channels.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Botalysofficial
• LinkedInlinkedin.com/company/botalys
• Instagraminstagram.com/botalys

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds11 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOTALYS